Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4

Journal of Experimental Medicine

Volumn 198, Issue 1, 2003, Pages 161-171

  Sugita, Sunao ^a   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Costimulatory molecules; Eye; Immune privilege; Inhibition; T lymphocytes

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD36 ANTIGEN; CD40 ANTIGEN; CD47 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; IRIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PIGMENT EPITHELIUM OF EYE; T-LYMPHOCYTES;

EID: 0037815115     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030097     Document Type: Article

References (30)

1. Streilen, J.W. 1993. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr. Opin. Immunol. 5:428-432.
2. Streilein, J.W. 1996. Ocular immune privilege and the faustian dilemma. Invest. Ophthalmol. Vis. Sci. 37:1940-1950.
3. Streilein, J.W., B.R. Ksander, and A.W. Taylor. 1997. Immune deviation in relation to ocular immune privilege. J. Immunol. 158:3557-3560.
4. Taylor, A.W. 1999. Ocular immunosuppressive microenvironment. Chem. Immunol. 73:72-89.
5. Streilein, J.W. 1997. Molecular basis of ACAID. Ocul. Immunol. Inflamm. 5:217-218.
6. Camacho-Hubner, A., and F. Beermann. 2001. Increased transgene expression by the mouse tyrosinase enhancer is restricted to neural crest-derived pigment cells. Genesis. 29: 180-187.
7. Streilein, J.W., and D. Bradley. 1991. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest. Ophthalmol. Vis. Sci. 32:2700-2710.
8. Knisely, T.L., P.A. Bleicher, C.A. Vibbard, and R.D. Granstein. 1991. Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells. Curr. Eye. Res. 10:761-771.
9. Tanihara, H., M. Yoshida, M. Matsumoto, and N. Yoshimura. 1993. Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 34:413-419.
10. Jorgensen, A., A.K. Wiencke, M. la Cour, C.G. Kaestel, H.O. Madsen, S. Hamann, G.M. Lui, E. Scherfig, J.U. Prause, A. Svejgaard, et al. 1998. Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest. Ophthalmol. Vis. Sci. 39:1590-1599.
11. Yoshida, M., M. Takeuchi, and J.W. Streilein. 2000. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest. Ophthalmol. Vis. Sci. 41:811-821.
12. Yoshida, M., T. Kezuka, and J.W. Streilein. 2000. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of regulatory T cells that suppress bystander T cells via TGF-β. Invest. Ophthalmol. Vis. Sci. 41:3862-3870.
13. Ishida, K., N. Panjwani, Z. Cao, and J.W. Streilein. 2003. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T cell activation by partially non-overlapping mechanisms. Ocul. Immunol. Inflamm. In press.
14. Bluestone, J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:555-559.
15. Geppert, T.D., L.S. Davis, H. Gur, M.C. Wacholtz, and P.E. Lipsky. 1990. Accessory cell signals involved in T-cell activation. Immunol. Rev. 117:5-66.
16. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
17. Carreno, B. M., and M Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29-53.
18. - peripheral T lymphocytes lack T44 (CD28), a surface molecule involved in activation of T cells bearing the alpha/beta heterodimer. Eur. J. Immunol. 17:1065-1068.
19. Greenwald, R.J., V.A. Boussiotis, R.B. Lorsbach, A.K. Abbas, and A.H. Sharpe. 2001. CTLA-4 regulates induction of anergy in vivo. Immunity. 14:145-155.
20. Scheipers, P., and H. Reiser. 1998. Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking. Proc. Natl. Acad. Sci. USA. 95:10083-10088.
21. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
22. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:303-309.
23. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:1335-1346.
24. Raulet, D.H. 1989. Immunology. Antigens for gamma/delta T cells. Nature. 339:342-343.
25. Nishida, T., and A.W. Taylor. 1999. Specific aqueous humor factors induce activation of regulatory T cells. Invest. Ophthalmol. Vis. Sci. 40:2268-2274.
26. Suda, T., T. Takahashi, and P. Golstein. 1993. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
27. Bellgrau, D., D. Gold, and H. Selawry. 1995. A role for CD95 ligand in preventing graft rejection. Nature. 377:630-632.
28. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
29. Steele, A., D. Uckan, P. Steele, W. Chamizo, K. Washington, A. Koutsonikolis, and R.A. Good. 1998. RT in situ PCR for the detection of mRNA transcripts of Fas-L in the immune-privileged placental environment. Cell Vis. 5:13-19.
30. Saas, P., P.R. Walker, M. Hahne, A.L. Quiquerez, V. Schnuriger, G. Perrin, L. French, E.G. Van Meir, N. de Tribolet, J. Tschopp, et al. 1997. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99:1173-1178.